ergonovine has been researched along with mibefradil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Berdeaux, A; Dubois-Randé, JL; Giudicelli, JF; Karila-Cohen, D | 1 |
2 other study(ies) available for ergonovine and mibefradil
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Effects of mibefradil on large and small coronary arteries in conscious dogs: role of vascular endothelium.
Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dogs; Endothelium, Vascular; Ergonovine; Heart Rate; In Vitro Techniques; Mibefradil; Tetrahydronaphthalenes; Vasodilation; Vasodilator Agents | 1996 |